Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May;2(3):203-10.
doi: 10.1177/1941738110366385.

Platelet-rich Plasma: Where Are We Now and Where Are We Going?

Affiliations
Free PMC article

Platelet-rich Plasma: Where Are We Now and Where Are We Going?

Brian J Cole et al. Sports Health. .
Free PMC article

Abstract

Context: Platelet-rich plasma (PRP) may affect soft tissue healing via growth factors released after platelet degranulation. Because of this potential benefit, clinicians have begun to inject PRP for the treatment of tendon, ligament, muscle, and cartilage injuries and early osteoarthritis.

Evidence acquisition: A PubMed search was performed for studies relating to PRP, growth factors, and soft tissue injuries from 1990 to 2010. Relevant references from these studies were also retrieved.

Results: Soft tissue injury is a major source of disability that may often be complicated by prolonged and incomplete recovery. Numerous growth factors may potentiate the healing and regeneration of tendons and ligaments. The potential benefits of biologically enhanced healing processes have led to a recent interest in the use of PRP in orthopaedic sports medicine. There has been widespread anecdotal use of PRP for muscle strains, tendinopathy, and ligament injuries and as a surgical adjuvant to rotator cuff repair, anterior cruciate ligament reconstruction, and meniscal or labral repairs. Although the fascination with this emerging technology has led to a dramatic increase in its use, scientific data supporting this use are still in their infancy.

Conclusions: The literature is replete with studies on the basic science of growth factors and their relation to the maintenance, proliferation, and regeneration of various tissues and tissue-derived cells. Despite the promising results of several animal studies, well-controlled human studies are lacking.

Keywords: early osteoarthritis; ligament injuries; muscle strain injuries; platelet-rich plasma; tendinopathy.

Conflict of interest statement

No potential conflict of interest declared.

Similar articles

See all similar articles

Cited by 47 articles

See all "Cited by" articles

References

    1. Akeda K, An HS, Okuma M, et al. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage. 2006;14(12):1272-1280 - PubMed
    1. Anand S, Viles-Gonzalez J, Badimon J, Cavusoglu E, Marmur J. Membrane-associated CD40L and sCD40L in antherothrombotic disease. Thromb Haemost. 2003;90(3):377-384 - PubMed
    1. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004;91(1):4-15 - PubMed
    1. Anonymous The Burden of Musculoskeletal Diseases in the United States. Washington, DC: Medical Expenditures Panel Survey, Agency of Healthcare and Quality, US Department of Health and Human Services; 1996-2004
    1. Aspenberg P, Virchenko O. Platelet concentrate injection improves Achilles tendon repair in rats. Acta Orthop Scand. 2004;75(1):93-99 - PubMed

LinkOut - more resources

Feedback